FOR IMMEDIATE RELEASE ON June 10, 2009

Neurology Journal Names Interim Editor-in-Chief

ST. PAUL, Minn. -

The ��ɫ���� (AAN) announced the appointment of Robert A. Gross, MD, PhD, FAAN, as interim Editor-in-Chief of its medical journal Neurology®, the world’s leading clinical neurology journal. Gross, who is with University of Rochester Medical Center in Rochester, New York, will replace John H. Noseworthy, MD, FAAN, who recently resigned from the position to become president and CEO of the Mayo Clinic. Prior to accepting the position, Gross served as Neurology’s Deputy Editor-in-Chief and on the publication’s Editorial Board for eight years. Gross is currently Director of the Strong Epilepsy Center and Professor of Neurology and of Physiology and Pharmacology at the University of Rochester Medical Center. He is a Fellow of the AAN and has been a member since 1984. “It is my distinct honor to guide Neurology following the journal’s continued success under Dr. Noseworthy’s insightful and strategic direction. He has helped to position Neurology as the premiere publication for disseminating cutting-edge, peer-reviewed information to the neurology community worldwide,” said Gross. “Under my leadership, we will continue to focus on providing busy office neurologists, residents and trainees, academic neurologists and researchers with convenient access to the latest information in order to advance neurology-focused patient care.” Neurology is the world’s most widely read and highly cited, peer-reviewed neurology journal and receives nearly 4,000 manuscript submissions annually, with about 66 percent of those coming from international researchers. Readers now enjoy Italian, Japanese, Polish, Spanish, Turkish, Korean, Chinese, and English editions of Neurology.

The ��ɫ����, an association of more than 21,000 neurologists and neuroscience professionals, is dedicated to promoting the highest quality patient-centered neurologic care through education and research. A neurologist is a doctor with specialized training in diagnosing, treating and managing disorders of the brain and nervous system such as stroke, Alzheimer’s disease, epilepsy, Parkinson’s disease, and multiple sclerosis. For more information about the ��ɫ����, visit www.aan.com or www.TheBrainMatters.org.